April 15, 2021 by Chain Drug Review
AllianceRx Walgreens Prime, oral FDA-approved therapies used to treat relapsing forms of multiple sclerosis (MS
Leading Headlines, Pharmacy
ORLANDO, Fla. — A recent study of patients receiving oral FDA-approved therapies used to treat relapsing forms of multiple sclerosis (MS) revealed high tolerance, low rates of adverse drug events, and similar medication adherence rates across all study medications. The retrospective study was conducted by AllianceRx Walgreens Prime, a leading specialty and home delivery pharmacy, in conjunction with Duquesne
February 8, 2021 by Chain Drug Review
AllianceRx Walgreens Prime
Leading Headlines, Pharmacy
ORLANDO, Fla.— AllianceRx Walgreens Prime is helping cancer patients prepare for challenges through multidisciplinary, holistic patient care, including access to more than 60 limited distribution oncology drugs. Most recently, Pfizer added to this list by granting the specialty pharmacy access to four targeted cancer therapies that treat metastatic melanoma, metastatic colorectal cancer, and two types
December 17, 2020 by Chain Drug Review
AllianceRx Walgreens Prime, Kesimpta (ofatumumab)
Leading Headlines, Pharmacy
ORLANDO, Fla. — Kesimpta (ofatumumab), the first and only self-administered, targeted B-cell therapy for patients with relapsing forms of multiple sclerosis (MS) in adults, is available through AllianceRx Walgreens Prime. MS is a rare disease of the central nervous system that affects nearly 1 million people in the United States, according to the National MS Society. MS disrupts the flow of information
November 16, 2020 by Chain Drug Review
AllianceRx Walgreens Prime, cancer patients, digital clinical assessment, James Adams
Leading Headlines, Pharmacy
ORLANDO, Fla. – Cancer patients who self-administer their therapy can now better manage their care online, thanks to the latest digital clinical assessment available only through AllianceRx Walgreens Prime. The newly-released self-serve tool simplifies patients’ online experiences when refilling their prescriptions. Earlier this year, AllianceRx Walgreens Prime announced the release of clinical assessments available for patients
October 29, 2020 by Chain Drug Review
AllianceRx Walgreens Prime, HRA Pharma Rare Diseases, Lysodren and Metopirone
Leading Headlines, Pharmacy
ORLANDO — HRA Pharma Rare Diseases has named AllianceRx Walgreens Prime – one of the largest specialty and home delivery pharmacies in the United States – as the exclusive specialty pharmacy and clinical support provider for two of its rare disease drugs, Lysodren and Metopirone. Lysodren (mitotane) is the only FDA-approved drug to treat inoperable, functional or
September 22, 2020 by Chain Drug Review
AllianceRx Walgreens Prime, Clayton Edwards
Leading Headlines, Pharmacy
ORLANDO, Fla. — Patients with chronic or complex conditions can better manage their care online, thanks to new digital clinical assessments available only through AllianceRx Walgreens Prime. In the wake of the global pandemic, the nation’s third largest specialty and home delivery pharmacy fast-tracked the release of these tools to simplify patients’ online experience when
September 16, 2020 by Chain Drug Review
AllianceRx Walgreens Prime, Rick Miller, The National Association of Specialty Pharmacy (NASP)
Leading Headlines, Pharmacy
ORLANDO, Fla. — The National Association of Specialty Pharmacy (NASP) has bestowed upon Rick Miller, vice president of clinical and professional services at AllianceRx Walgreens Prime, the Distinguished Service Award at the opening general session of its 2020 annual meeting. The Distinguished Service Award is given to the individual who has made a sustained contribution to
August 27, 2020 by Chain Drug Review
AllianceRx Walgreens Prime, Inqovi
Pharmacy
ORLANDO, Fla. — Adults with certain types of rare blood cancers can now receive their treatment in the comfort of their own home, thanks to a new medication available through a limited distribution with AllianceRx Walgreens Prime. Inqovi (decitabine and cedazuridine), manufactured by Taiho Oncology, treats adult patients with myelodysplastic syndromes (MDS) (a type of blood cancer) and
August 6, 2020 by Chain Drug Review
AllianceRx Walgreens Prime, Ed Musisko
Leading Headlines, Pharmacy
ORLANDO, Fla. — A new patented process for delivering specialty medicine will assure AllianceRx Walgreens Prime patients receive their medicine delivered at the correct temperature. AllianceRx Walgreens Prime, one of the nation’s largest specialty and home delivery pharmacies, will exclusively use the patent – held by parent company Walgreens – to help increase patient safety, improve patient
May 19, 2020 by Chain Drug Review
AllianceRx Walgreens Prime, Lundbeck, Tracey James
Leading Headlines, Pharmacy
ORLANDO, Fla. — Lundbeck, a global pharmaceutical company specializing in brain diseases, has named AllianceRx Walgreens Prime one of only two specialty pharmacies to distribute its newest medication for the preventive treatment of migraine in adults. The medication, Vyepti (eptinezumab-jjmr), is the first and only intravenous preventive treatment for migraine. Migraine is a complex and incapacitating neurological
May 11, 2020 by Chain Drug Review
AllianceRx Walgreens Prime, cancer, Lakyn Husinka
Leading Headlines, Pharmacy
ORLANDO, Fla. —A recent study of metastatic breast cancer (MBC) patients, prescribed a class of drugs that interrupt malignant cell growth, revealed high rates of adherence, low side effects and low rates of patients stopping their medication. The class of drugs is known as cyclin-dependent kinase (CDK) 4/6 inhibitors. The retrospective study was conducted by AllianceRx
May 6, 2020 by Chain Drug Review
AllianceRx Walgreens Prime, National Association of Specialty Pharmacy (NASP), ProCE, Rick Miller, Sheila Arquette
Leading Headlines, Pharmacy
ORLANDO, Fla. — AllianceRx Walgreens Prime has renewed its sponsorship of accredited, web-based continuing education (CE) customized for members of the National Association of Specialty Pharmacy (NASP), which includes AllianceRx Walgreens Prime pharmacists. The CE content is accredited, managed and delivered through ProCE, a nationally recognized provider of CE for healthcare professionals. “We are proud to
September 11, 2019 by Chain Drug Review
AllianceRx Walgreens Prime, National Association of Specialty Pharmacy, Rick Miller
Leading Headlines, Pharmacy
ORLANDO, Fla. — AllianceRx Walgreens Prime announced results from a new study analyzing data from patients prescribed interleukin-17 (IL-17) inhibitors for psoriasis. Patients reported improvements in psoriatic symptoms and demonstrated increased medication adherence after switching to one of the three IL-17 medications included in the study. The study was conducted with Walgreens, a parent company of
August 26, 2019 by Chain Drug Review
AllianceRx Walgreens Prime, limited distribution drugs (LDDs), Tracey James
August 26, 2019, News
ORLANDO, Fla. — AllianceRx Walgreens Prime has announced additional medicines available to patients with certain rare, chronic and complex conditions. Known as limited distribution drugs (LDDs), these specialty medicines treat certain types of multiple sclerosis (MS), Lambert-Eaton myasthenic syndrome (LEMS) and a form of non-Hodgkin’s lymphoma (NHL), among other complex conditions. Since last spring, the
